Does PALBOCICLIB Cause Rash erythematous? 144 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 144 reports of Rash erythematous have been filed in association with PALBOCICLIB (Ibrance). This represents 0.2% of all adverse event reports for PALBOCICLIB.
144
Reports of Rash erythematous with PALBOCICLIB
0.2%
of all PALBOCICLIB reports
0
Deaths
23
Hospitalizations
How Dangerous Is Rash erythematous From PALBOCICLIB?
Of the 144 reports, 23 (16.0%) required hospitalization.
Is Rash erythematous Listed in the Official Label?
Yes, Rash erythematous is listed as a known adverse reaction in the official FDA drug label for PALBOCICLIB.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Rash erythematous?
DUPILUMAB (5,197)
ADAPALENE (2,478)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (1,924)
ADALIMUMAB (1,303)
ETANERCEPT (998)
RITUXIMAB (792)
TOCILIZUMAB (764)
ACETAMINOPHEN (741)
METHYLPREDNISOLONE (699)
PANTOPRAZOLE (677)
Which PALBOCICLIB Alternatives Have Lower Rash erythematous Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID